Science Daily7h
Clinical trial shows positive results for potential treatment to combat a challenging rare disease
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Many long COVID patients adjust to slim recovery odds as world moves on
There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, ...
New tools can help with early detection of kidney disease | Opinion
Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.
devdiscourse1d
Living with Long COVID: Navigating a New Normal Amid Waning Attention
Wachuka Gichohi shares her journey with long COVID, experiencing debilitating symptoms for four years. Despite scientific advancements, attention and funding for research are decreasing, especially in ...
Pain and perception—exploring the mind–body connection in treating chronic pain
Better understanding of the complex relationship between mind and body may provide new treatment strategies for chronic pain, ...
It’s the illness that has no cure. But this doctor believes he’s found answer to chronic fatigue syndrome
In 1989 a patient with myalgic encephalomyelitis (ME) came to see Dr Raymond Perrin in his capacity as an osteopath. The man ...